Company Financials

Amgen Financials

United States dollar

business Amgen Company Profile

Main Stock Listing

NASDAQ: AMGN

Market Capitalization $159.62 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 27.04
Forward PE 14.36
Price to Sales TTM $4.68
Price to Book MRQ $25.71
Enterprise to Revenue 5.82
Enterprise to EBITDA 12.64

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 17.39%
Operating Margin 28.73%
Return on Assets TTM 7.04%
Return on Equity TTM 105.67%

Income Statement

Revenue TTM $34,126,000,128
Revenue per Share TTM $63.49
Quarterly Revenue Growth 9.40%
Gross Profit TTM $23,569,999,872
EBITDA $15,284,000,000
Net Income to Common TTM $5,933,000,192
Diluted EPS TTM $10.98
Quarterly Earnings Growth YoY 9.43%

Balance Sheet

Total Cash MRQ $8,810,000,384
Total Cash per Share MRQ $16.38
Total Debt MRQ $
Total Debt to Equity MRQ 924.46
Current Ratio MRQ 1.17
Book Value per Share MRQ $11.54

Cash Flow

Operating Cash Flow TTM $12,192,000,000
Levered Free Cash Flow TTM $13,090,124,800

AMGN Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 537,000,000
Float Shares 536,334,967
Avg 10 Volume 3,565,110
Avg 30 Volume None
Shares Short 13,271,690
Short Ratio 4.94
Short % of Shares 2.48%
% Held by Insiders 0.21%
% Held by Institutions 83.59%

Stock Price Summary

Beta 0.50
Fifty Two Week Low $253.30
Fifty Two Week High $346.85
Fifty Two Week Change -4.24%
Day 50 MA $281.21
Day 200 MA $294.21

Dividends and Splits

Forward Annual Dividend Rate $9.52
Forward Annual Dividend Yield 3.19%
Trailing Annual Dividend Rate $9.26
Trailing Annual Dividend Yield 3.10%
Payout Ratio 83.23%
Dividend Date 2025-06-06
Ex Dividend Date 2025-05-16
Last Split Factor
Last Split Date 1999-11-22